Concepedia

Blas A. Guigni

BA

Statistics

Publications

21

Citations

1.8K

H-Index

18

Active since

2011

Affiliations

Howard Hughes Medical Institute(Current)

Yale University

University of Vermont

Ionis Pharmaceuticals (United States)

Defense Center for Public Health - Aberdeen

Blas A. Guigni is an author at Howard Hughes Medical Institute specializing in life sciences, hepatic insulin resistance, and endocrinology.

ORCID

Publications per year

2011–2023

21

Publications

21

Cellular Mechanisms by Which FGF21 Improves Insulin Sensitivity in Male Mice

João Paulo Camporez, François R. Jornayvaz, Max C. Petersen et al. · Endocrinology · 2013 · 221 citations · Full text

, , +16

Cellular Mechanism by Which Estradiol Protects Female Ovariectomized Mice From High-Fat Diet-Induced Hepatic and Muscle Insulin Resistance

João Paulo Camporez, François R. Jornayvaz, Hui‐Young Lee et al. · Endocrinology · 2013 · 199 citations · Full text

, , +17

Targeting Pyruvate Carboxylase Reduces Gluconeogenesis and Adiposity and Improves Insulin Resistance

Naoki Kumashiro, Sara A. Beddow, Daniel F. Vatner et al. · Diabetes · 2013 · 161 citations · Full text

, , +17

CGI-58 knockdown sequesters diacylglycerols in lipid droplets/ER-preventing diacylglycerol-mediated hepatic insulin resistance

Jennifer Cantley, Toru Yoshimura, João Paulo Camporez et al. · Proceedings of the National Academy of Sciences · 2013 · 159 citations · Full text

, , +17

Hepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2

François R. Jornayvaz, Andreas L. Birkenfeld, Michael J. Jurczak et al. · Proceedings of the National Academy of Sciences · 2011 · 158 citations

, , +17

1–5 of 21